MDxHealth (MDXH) filed a shelf registration to sell up to $200 million in shares, including a $50 million at-the-market program and a secondary resale of 1.87 million shares held by a selling stockholder.
Proceeds will be used in part to finance product development and expand commercial activities, the company said Monday in a regulatory filing.